Application of Laser Capture Microdissection and Microarray on Analysis of Differential Gene Expression in Cancer

ZHANG Yun-fei,ZHANG Hua,ZHANG Bao-qun,WANG Hai-tao,CHEN Chao

DOI: https://doi.org/10.3969/j.issn.1673-713x.2007.05.004

2007-01-01

Abstract:Objective To find a feasible technique to combine laser capture microdissection (LCM) with microarray for analysis of differential gene expression in cancer. Methods By using LCM, bladder transitional cell carcinoma (BTCC) cells and adjacent normal cells were obtained from frozen sections preserved after operation . RNA was extracted from the cells, and RNA integrity number (RIN) was analyzed by Agilent 2100 Bioanalyzer. Then, aRNA probe was obtained by linear RNA amplification (100 ng) and fluorescent labeling; the tumor tissues were labeled with Cy5 and the adjacent noncancerous tissues were labeled by Cy3. Afterwards, the aRNA probes were hybridized with Agilent human 1A oligo microarray. The false positive rate (FPR) was calculated by comparing the number of false positive gene in a same sample to evaluate the reliability of the results. The differential gene expression between the tumor and adjacent normal tissues were detected by analyzing the data. Results All the RIN obtained in this study was 8.0, indicating a high integrity of the RNA extracted by using LCM. After the linear RNA amplification and fluorescent labeling, the 100 ng RNA produced about 16 μg aRNA probe with a fragment size of 0.5-2.5 kb. The FPR1% showed that the system was reliable. Compared with the adjacent normal tissues, 286 up-regulated and 112 down-regulated genes were identified in the tumor tissues. Conclusions The RNA extracted from cells by using LCM is applicable to produce microarray probe. The result of the microarray hybridization is reliable, showing that the technique is feasible in analysis of differential gene expression in cancer.